IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

Frontiers A neutralizing bispecific single-chain antibody against SARS-CoV -2 Omicron variant produced based on CR3022

Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus

Viruses, Free Full-Text

Full article: Therapeutic antibodies for COVID-19: is a new age of IgM, IgA and bispecific antibodies coming?

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance

IJMS, Free Full-Text

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern